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Abstract  
Objective: To explore the impact of different feedback strategies on 1) subsequent agreement and 2) 
variability in Delphi studies. 
Study Design and Setting: A two-round Delphi survey, with a list of outcomes generated from the 
results of a systematic review and interviews, was undertaken whilst developing a core outcomes set 
for prostate cancer including two stakeholder groups (health professionals and patients). Seventy-
nine outcomes were scored on a scale of one (not important) to nine (critically important). Participants 
were randomised in round two to receive round one feedback from: peers only, multiple stakeholders 
separately, or multiple stakeholders combined.  
Results: Agreement on outcomes retained for all feedback groups was high (peer: 92%, multiple 
separate: 90%, multiple combined: 84%). There were no statistically significant reduction in variability 
for peer versus multiple-separate (0.016 (-0.035, 0.067); p=0.529), or multiple-separate versus 
multiple-combined feedback (0.063 (-0.003, 0.129); p=0.062). Peer feedback statistically significantly 
reduced variability compared to multiple-combined feedback (0.079 (0.001, 0.157); p=0.046). 
Conclusions: We found no evidence of a difference between different feedback strategies in terms of 
the number of outcomes retained or reduction in variability of opinion. However, this may be 
explained by the high level of existing agreement in round one. Further methodological studies nested 
within Delphi surveys will help clarify the best strategy.   
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 1. Introduction 
A core outcome set (COS) is an agreed minimum set of outcomes which should be reported in all 
effectiveness trials of an intervention or condition. [1] Reaching consensus on the most important 
outcomes to measure in clinical trials for stakeholders with potentially diverse opinions, such as 
patients and health professionals, is central to maximising the efficiency of clinical trials of 
effectiveness. [2] If there is consensus on what outcomes ought to be measured, then heterogeneity 
in the range of outcomes reported will reduce, selective outcome reporting will be reduced, evidence 
synthesis will be easier to perform, and the results are likely to be more informative.  The COMET 
initiative have promoted methods to facilitate achieving consensus on COS. [3] A transparent way to 
incorporate diverse opinions and move toward consensus is to use Delphi surveys. Delphi surveys use 
more than one round of a questionnaire, with feedback after the first round, to elicit opinion on, for 
example, how important the participants think each outcome is. A strength of the Delphi method is 
that because the questionnaires are completed by participants anonymously and in isolation, they are 
not prone to social influences such as dominant personalities or pressure to conform to the majority, 
or to agree with perceived experts, [4, 5] yet still give participants an opportunity to consider and 
revise their own opinions in light of what other participants think. Additionally, using online surveys, 
Delphi techniques are not limited by geography. [5] Around 30% of core outcome set development 
projects listed in the COMET database incorporate Delphi methods. [6]   
When asking participants to re-score outcomes in the subsequent Delphi round(s), in addition to 
reminding the participant of their own score, there are a few options available with regard to the type 
of feedback given. These include showing participants a summary of what their own stakeholder 
group’s scores were (peer only), showing them a summary of the other stakeholder group’s scores 
also (multiple separate), or showing a combined summary of all participants’ scores regardless of 
stakeholder group (multiple combined). Furthermore, the type of data used to summarise the 
feedback could be a measure of central tendency, such as mean or median scores, or distributions of 
What is new? 
Key findings: We found no meaningful differences between the various feedback groups 
What this adds to what is known: Despite this, the results are not inconsistent with other 
exploratory research showing that multiple separate feedback benefits agreement and reduces 
variability. This study added a new feedback strategy (multiple combined) which has not been 
studied in previous research. 
What is the implication, what should change now: Further nested research using similar 
methods to investigate the influence of different types of feedback will help clarify the best 
strategy to be used in future Delphi studies in the context of COS development 
the number of participants choosing each score for each outcomes, such as a histogram. Mean or 
median scores are proposed to be generally easier to understand but may also mask important 
divergences in opinion. Showing a distribution of scores is less succinct, and may be harder to 
assimilate, but gives more detailed information on diverse opinions if they exist. [1] 
Whilst there is some evidence from social psychology that different presentation of feedback between 
rounds may influence subsequent scores differently, [4] there is no guidance on the optimal strategy 
as yet. Brookes et al recently published exploratory research from three COS Delphis comparing 
responses of participants randomised to receive peer-only or multiple separate stakeholder feedback 
using mean scores from the previous round to communicate the information. [7]  Their results 
suggested consistently and statistically significantly that multiple separate feedback increased 
agreement on the number of outcomes retrained by both stakeholder groups after round two and 
reduced variability between rounds compared to peer-only feedback.  
In this study we report the results of a nested randomised controlled trial (RCT) comparing peer-only, 
multiple separate and multiple combined feedback. Formally investigating feedback strategy is a new 
methodological concept in Delphi studies used in COS development. It is still unclear which strategies 
might reduce the number of retained or reduce the variability and therefore we do not state 
directionality in the hypotheses we used.  
The exploratory hypotheses tested were: 
1. There is a difference in the number of outcomes retained after Delphi round two between 
peer-only, multiple single and multiple combined feedback (agreement).  
2. There is a difference in the variability of outcome scores after Delphi round two between peer-
only, multiple single and multiple combined feedback (variability).   
2. Materials and Methods 
This nested RCT was undertaken within the development of a protocol-driven COS for localised 
prostate cancer [8, 9] and the study was approved by the National Research Ethics Service (NRES) – 
North of Scotland Committee (reference 12/NS0042). The list of outcomes for inclusion in the Delphi 
questionnaire were identified through a systematic review of the literature and semi-structured 
interviews with men who had been treated for localised prostate cancer. Verbatim outcomes were 
recoded to common names. This generated a list of 79 outcomes which were used in the Delphi 
questionnaire. [9] Methodological details about the design and analysis of the systematic review, and 
semi-structured interviews and the methods for the nested RCT are available in the study protocol [8] 
and the main COS report [9]. An overview of the Delphi creation process can be seen in Figure 1. A list 
and description of all 79 outcomes and can be viewed in appendix 2 of the main COS development 
paper. [9] We reported the main study in accordance with the Core Outcome Set-STAndards for 
Reporting (COS-STAR) Statement. [10] 
All outcomes where entered into a bespoke online Delphi tool, written in C# using WebForms and a 
MySQL backend. Two stakeholder groups were invited to participate via email: patients (men who 
received any treatment type for localised prostate cancer) and health professionals (urological 
surgeons, uro-oncologists, medical oncologists and urological cancer nurse specialists). Participants 
were asked “How important are the following outcomes in making decisions regarding treatments?” 
The Delphi questionnaire was completed online. Participants were directed to score the importance 
of each outcome on a 9-point scale. This scale was adapted from GRADE [11] (i.e. 1-3 = not important; 
4-6 = important; 7-9 = critical; together with an ‘unable to score’ option). All Delphi outcomes were 
accompanied by a lay description and all participants saw the same questionnaire and descriptions. 
All participants completing round one were invited to complete round two. In round two participants 
were shown their score from the previous round and were centrally randomised on a 1:1 ratio, using 
variable block randomisation, to be shown one of three additional feedback options:  
1. The ‘peer’ group received feedback from their own stakeholder group only  
2. The ‘multiple separate’ group received feedback from their own stakeholder group and the 
other stakeholder group separately 
3. The ‘multiple combined’ group received feedback from their own stakeholder group and the 
other stakeholder group combined  
Central randomisation via the online Delphi software enabled allocations to be concealed from the 
research team. Participants could not be blinded to which feedback group they were allocated to 
precisely because of the nature of the study, but the research team were blinded to allocation until 
the analysis stage. An example of what the participants were shown in round two is depicted in Figure 
2. All outcomes were retained after round one and all participants saw and had the opportunity to 
rescore all outcomes in round two. 
2.1 Sample size 
This was an opportunistic sample and the statistical testing was intended to be exploratory.  
2.2 Analysis 1: Agreement between stakeholders and between participants 
randomised to different feedback groups  
To investigate hypothesis one (there is a difference in the number of outcomes retained after Delphi 
round two between peer only, multiple single and multiple combined feedback) we analysed the 
numbers of outcomes the stakeholder groups agreed on. To do this, after round two, outcomes scored 
as critical (i.e. 7-9) by ≥70% of patients and HCPs separately AND not important (i.e. 1-3) by <15% of 
patients and HCPs separately after round one were considered ‘retained’. Retained outcomes were 
identified for patients and health professionals separately.  We then calculated the number of 
outcomes retained for a) both stakeholder groups (agreement); b) neither group (agreement); and c) 
each stakeholder group independently (i.e. discordant) for each of the three feedback groups. 
2.3 Analysis 2:   Differences in variability between participants randomised to different 
feedback groups  
To investigate hypothesis two (there is a difference in the variability of item scores after Delphi 
round two between peer only, multiple single and multiple combined feedback), for each of the 79 
items, we computed the standard deviation of scores across all participants (ignoring stakeholder 
group) for each feedback group. This was done separately for round one and round two and the 
reduction in variability between rounds calculated. The mean reductions in standard deviations were 
compared, across all items, using paired t-tests for the peer versus multiple separate, peer versus 
multiple combined, and multiple separate versus multiple combined feedback groups. 
 
3. Results  
Of the 153 patients and 110 health professionals invited to participate in the Delphi, 118 patients 
(77%) and 56 health professionals (51%) completed round 1 indicating that initial response  rates were 
lower for health professionals than patients. Both groups had good retention for round two at 92% 
(109/118) and 88% (49/56) for patients and health professionals respectively. The mean (SD) scores 
for 13 participants dropping out after round one (6 (1.3)) did not differ markedly from those remaining 
in the study (5.8 (1.6)). The numbers randomised to each feedback group are shown in Figure 3. 
The numbers and percentages of participants changing at least one score between round one and 
round two can be seen in Figure 4. Regardless of stakeholder and randomised group, a high 
percentage of participants changed their scores from round one to round two (≥ 88%). In instances 
where a participant changed scores between rounds a free-text pop-up box asked them to give a 
reason why. This was for any score change regardless of how large or small, and giving a reason was 
optional. Of the 146 who changed their score, 110 (75%) filled in the free text box to explain their 
reason for changing score. Patients (86/102; 84%) commented more often than health professionals 
(24/44; 55%). The qualitative responses were coded. Some participant’s comments were coded with 
more than one category. The most frequently given reasons for score change, regardless of 
stakeholder group or feedback, were that participants had ‘time to reflect’ between rounds (56/110; 
51%), or that knowledge of ‘other’s scores’ had influenced them (36/110; 33%).  Although the 
sample sizes are very small, it is interesting to note that of the health professionals who commented, 
those who saw peer only feedback were more likely justify score change with the ‘influence of 
other’s’ scores (7/10; 70%) than those who saw multiple separate (3/7; 42%) or multiple combined 
feedback (4/7; 57%). No such differences were seen in the patient group. Some patients, however, 
stated that their perception of the outcome had changed since the previous iteration of the 
questionnaire. 
 
3.1 Agreement between stakeholders and between participants randomised to 
different feedback groups 
The number of outcomes retained and the number of outcomes where there was agreement or 
discordance after applying the pre-specified criteria is shown in table 1a. Percent agreement was high 
across all feedback groups but the peer feedback group (92%) retained marginally more outcomes 
compared to 87% in the multiple combined group, and 90% in the multiple separate group. The 
absolute percent difference was very low and ranged from 2% in the peer compared to multiple 
separate to 5% in the peer compared to multiple combined groups. 
To explore this finding further we repeated the analysis for round one. The results are shown in table 
1b which shows that agreement between stakeholder groups was already very good at the outset in 
this Delphi: it was 84% in the multiple combined group, 90% in the multiple separate group and 91% 
in the peer feedback group. 
3.2 Differences in variability between participants randomised to different feedback 
groups 
As table 2 shows Peer feedback (0.22 (0.19)) was marginally better at reducing the average variability 
in scores compared to multiple separate (0.20 (0.12)) or multiple combined (0.14 (0.25)) feedback. 
However, the magnitude of effects was very small. The results of the pairwise comparisons are shown 
in table 3. Peer only feedback was statistically significantly better at reducing variability compared to 
multiple combined feedback (0.079 (0.001, 0.157); p=0.046) but this was not felt to be a meaningful 
difference. There were no statistically significant differences showing that peer only was better than 
multiple separate feedback for reducing variability (0.016 (-0.035, 0.067); p=0.529)). Likewise for 
multiple separate compared to multiple combined feedback (0.063 (-0.003, 0.129); p=0.062). 
4. Discussion 
The nested methods study shows no evidence of a difference between different feedback strategies 
in terms of the number of outcomes retained nor in reducing variability. However, this may be 
explained by the good agreement in round one. There are some limitations to the study. For example 
the small sample size in the healthcare professional group resulted in relatively small numbers 
allocated to each of the 3 feedback groups (n ~15). Another limitation is the fact that all of the patient 
participants, and most of the health professional participants were from and were from the United 
Kingdom. A larger and more geographically diverse participant group may have shown greater 
divergence in opinion at the outset. If there had been greater variability in opinion at baseline then 
we may have seen clearer differences in the influence of different feedback strategies. Also, our study 
asked participants to score 79 outcomes which, although necessary for the aim of the main core 
outcome set development project, may have been burdensome to score on three separate occasions. 
However, it is not clear how this may have affected scoring. 
4.1 Comparison with other studies 
Brooke’s et al [7] also compared peer with multiple separate (but not multiple combined) feedback 
and the similarity in methods allows some comparison of the results across the two studies. Brookes 
et al explored the effect of peer versus multiple separate feedback in three separate Delphis: breast 
reconstruction surgery, surgery for colorectal cancer and surgery for oesophageal cancer. They 
consistently found that agreement was better when participants were shown multiple separate 
feedback as shown in table 4.  With regards to variability, Brookes et al found that multiple separate 
feedback consistently and statistically significantly reduced variability, whereas our prostate cancer 
Delphi showed no evidence of a difference as presented in the Forest plot in figure 5.  
It is important to note that in the colorectal Delphi and the oesophageal Delphi, where there was a 
more pronounced effect in favour of multiple separate feedback, there was poorer initial agreement 
between stakeholder groups. Whereas in the breast reconstruction Delphi, albeit still finding a 
statistically significant result in favour of multiple separate feedback, the results are more in keeping 
with our findings. These differences then may be explained by the comparatively better initial 
agreement between stakeholder groups in the breast Delphi and prostate Delphi. In summary, the 
95% CIs in our prostate cancer Delphi do not disagree with Brookes et al’s results, but suggest that 
differences may not be as large as Brookes et al found. However, more research is needed to clarify 
these trends.  
Other methodological differences between the prostate Delphi and the three Delphis reported by 
Brookes et al are 1) the prostate Delphi tested three feedback strategies instead of two and had a 
smaller number of participants in each feedback allocation group; 2) the prostate Delphi retained all 
outcomes throughout all rounds of the Delphi, whereas the other three Delphis dropped outcomes 
not meeting scoring thresholds after round 1 (i.e. only outcomes which scored between 7-9 by 50% 
or more participants and between 1-3 by less than 15% (done separately for each stakeholder group) 
were retained after round one in Brookes et al’s Delphis); and 3) the prostate Delphi presented 
feedback as the percentage of participants scoring each outcome at each possible score from 1-9, 
whereas the other three presented feedback as mean scores. It is currently unclear how any of these 
methodological differences may influence results and further research is required to investigate these.   
For future Delphi studies, an important point to bear in mind is that if agreement is already good 
between stakeholder groups, then the type of feedback given may not make any difference to the 
results. Conversely, in instances where initial agreement is poor, multiple separate feedback may be 
a better strategy to reach consensus. Also, a priori, we planned three rounds of Delphi which was time 
consuming to complete. Future studies could propose to analyse results after each round to assess 
agreement and, according to predefined thresholds of agreement, could use these results to decide 
whether is necessary to have subsequent Delphi rounds.   
5. Conclusion  
In summary, our study found no meaningful differences between the various feedback groups. Despite 
this, the results are not inconsistent with Brookes et al’s finding that multiple separate feedback 
benefits agreement and reduces variability. Further nested research using similar methods to 
investigate the influence of different types of feedback will help clarify the best strategy to be used in 
future Delphi studies in the context of COS development.  
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